Literature DB >> 30918415

Validating the Communicative Participation Item Bank (CPIB) for use with people with aphasia: an analysis of Differential Item Function (DIF).

Carolyn Baylor1, Megan Oelke2, Alyssa Bamer3, Eileen Hunsaker4, Catherine Off5, Sarah E Wallace6, Suzanne Pennington7, Diane Kendall8, Kathryn Yorkston9.   

Abstract

BACKGROUND: The term 'communicative participation' refers to participation in the communication aspects of life roles at home, at work, and in social and leisure situations. Participation in life roles is a key element in biopsychosocial frameworks of health such as the World Health Organization's (WHO) International Classification of Functioning, Disability and Health (ICF), and the Aphasia Framework for Outcomes Measurement (AFROM). The Communicative Participation Item Bank (CPIB) was developed as a patient-reported measure of communicative participation for adults. Initial validation focused on adults with motor speech or voice disorders. No prior studies have conducted quantitative validation analyses for the CPIB for persons with aphasia (PWA). AIMS: The primary purpose of this study was to begin validation of the CPIB for PWA by conducting an analysis of differential item functioning (DIF). A DIF analysis was used to identify whether item parameters of the CPIB differed between PWA and the populations used in prior CPIB calibration. Secondary analyses evaluated the level of assistance needed by PWA to complete the CPIB, relationships between the CPIB and a gold-standard patient-reported instrument for PWA - American Speech-Language-Hearing Association Quality of Communication Life Scale (ASHA-QCL), and relationships between PWA and family proxy report on the CPIB. METHODS AND PROCEDURES: This study included 110 PWA and 90 proxy raters. PWA completed a battery of patient-reported questionnaires in one face-to-face session. Speech-language pathologists (SLPs) provided communication support. Data on aphasia severity from the Western Aphasia Battery - Revised (WAB-R) and demographic data either existed from prior research or were collected during the session. Proxy raters completed a similar battery of self-report questionnaires. OUTCOMES AND
RESULTS: Results of the DIF analysis suggested statistically significant DIF on two of the 46 items in the CPIB, but the DIF had essentially no impact on CPIB scores. PWA with WAB-R Aphasia Quotient scores above 80 appeared comfortable reading the CPIB items, although required occasional assistance. Most participants who were unable to complete the CPIB had WAB-R Aphasia Quotient scores lower than 50. Correlation between the CPIB and ASHA-QCL was moderate; and correlation between PWA and proxy scores was low.
CONCLUSIONS: Most PWA were able to respond to CPIB items, although most required or requested support. Although these results are preliminary due to a small sample size, the data support that the CPIB may be valid for PWA. Caution is warranted regarding proxy report because of low correlation between PWA and proxy ratings.

Entities:  

Keywords:  Aphasia; Communicative participation; Patient-reported outcomes; Proxy; Quality of life

Year:  2016        PMID: 30918415      PMCID: PMC6433404          DOI: 10.1080/02687038.2016.1225274

Source DB:  PubMed          Journal:  Aphasiology        ISSN: 0268-7038            Impact factor:   2.773


  26 in total

1.  Procedures for the analysis of differential item functioning (DIF) for small sample sizes.

Authors:  Jin-Shei Lai; Jeanne Teresi; Richard Gershon
Journal:  Eval Health Prof       Date:  2005-09       Impact factor: 2.651

Review 2.  Towards an international framework for communication disorders: use of the ICF.

Authors:  Travis T Threats
Journal:  J Commun Disord       Date:  2006-04-04       Impact factor: 2.288

3.  Measuring communicative participation: a review of self-report instruments in speech-language pathology.

Authors:  Tanya L Eadie; Kathryn M Yorkston; Estelle R Klasner; Brian J Dudgeon; Jean C Deitz; Carolyn R Baylor; Robert M Miller; Dagmar Amtmann
Journal:  Am J Speech Lang Pathol       Date:  2006-11       Impact factor: 2.408

4.  The consequences of spasmodic dysphonia on communication-related quality of life: a qualitative study of the insider's experiences.

Authors:  Carolyn R Baylor; Kathryn M Yorkston; Tanya L Eadie
Journal:  J Commun Disord       Date:  2005 Sep-Oct       Impact factor: 2.288

5.  Proxy and self-report agreement on the Stroke and Aphasia Quality of Life Scale-39.

Authors:  Katerina Hilari; Sophie Owen; Sharon Jane Farrelly
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-01-26       Impact factor: 10.154

6.  Psychometric evaluation and calibration of health-related quality of life item banks: plans for the Patient-Reported Outcomes Measurement Information System (PROMIS).

Authors:  Bryce B Reeve; Ron D Hays; Jakob B Bjorner; Karon F Cook; Paul K Crane; Jeanne A Teresi; David Thissen; Dennis A Revicki; David J Weiss; Ronald K Hambleton; Honghu Liu; Richard Gershon; Steven P Reise; Jin-shei Lai; David Cella
Journal:  Med Care       Date:  2007-05       Impact factor: 2.983

7.  Life with communication changes in Parkinson's disease.

Authors:  Nick Miller; Emma Noble; Diana Jones; David Burn
Journal:  Age Ageing       Date:  2006-03-15       Impact factor: 10.668

8.  Work integration issues go beyond the nature of the communication disorder.

Authors:  Linda J Garci; Chantal Laroche; Jacques Barrette
Journal:  J Commun Disord       Date:  2002 Mar-Apr       Impact factor: 2.288

9.  Stroke and Aphasia Quality of Life Scale-39 (SAQOL-39): evaluation of acceptability, reliability, and validity.

Authors:  Katerina Hilari; Sally Byng; Donna L Lamping; Sarah C Smith
Journal:  Stroke       Date:  2003-07-10       Impact factor: 7.914

10.  Developing a scale of communicative participation: a cognitive interviewing study.

Authors:  Kathryn M Yorkston; Carolyn R Baylor; Jean Dietz; Brian J Dudgeon; Tanya Eadie; Robert M Miller; Dagmar Amtmann
Journal:  Disabil Rehabil       Date:  2008       Impact factor: 3.033

View more
  7 in total

1.  Achieving Participation-Focused Intervention Through Shared Decision Making: Proposal of an Age- and Disorder-Generic Framework.

Authors:  Carolyn Baylor; Meghan Darling-White
Journal:  Am J Speech Lang Pathol       Date:  2020-05-28       Impact factor: 2.408

2.  Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia.

Authors:  Angela C Roberts; Alfred W Rademaker; Elizabeth Ann Salley; Aimee Mooney; Darby Morhardt; Melanie Fried-Oken; Sandra Weintraub; Marsel Mesulam; Emily Rogalski
Journal:  Trials       Date:  2022-06-13       Impact factor: 2.728

3.  Relationship between perceived social support and patient-reported communication outcomes across communication disorders: a systematic review.

Authors:  Tanya Eadie; Mara Kapsner-Smith; Susan Bolt; Cara Sauder; Kathryn Yorkston; Carolyn Baylor
Journal:  Int J Lang Commun Disord       Date:  2018-07-24       Impact factor: 3.020

4.  Association Between Communicative Participation and Psychosocial Factors in Patients With Voice Disorders.

Authors:  Viann N Nguyen-Feng; Alexa Asplund; Patricia A Frazier; Stephanie Misono
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2020-12-23       Impact factor: 6.223

5.  Communicative Participation in Dysarthria: Perspectives for Management.

Authors:  Allyson D Page; Kathryn M Yorkston
Journal:  Brain Sci       Date:  2022-03-22

6.  Communication Limitations in Patients With Progressive Apraxia of Speech and Aphasia.

Authors:  Rene L Utianski; Heather M Clark; Joseph R Duffy; Hugo Botha; Jennifer L Whitwell; Keith A Josephs
Journal:  Am J Speech Lang Pathol       Date:  2020-08-05       Impact factor: 2.408

7.  Clinical Use of PROMIS, Neuro-QoL, TBI-QoL, and Other Patient-Reported Outcome Measures for Individual Adult Clients with Cognitive and Language Disorders.

Authors:  Matthew L Cohen; Alyssa M Lanzi; Aaron J Boulton
Journal:  Semin Speech Lang       Date:  2021-07-14       Impact factor: 1.734

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.